DMC Biotechnologies produces bio-based chemicals using fermentation.
DMC Biotechnologies produces bio-based chemicals using fermentation. The company's technology makes products using lower energy and resources, with applications that contribute to a sustainable economy. DMC Biotechnologies, Inc. was founded in 2014 by Matt Lipscomb and Mike Lynch and is based in Boulder, Colorado, United States.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 2, 2021 | Series B | $39M | 1 | — | — | Detail |
Dec 18, 2019 | Series A | $11.30M | 1 | — | — | Detail |
Aug 30, 2017 | Grant | $1.33M | 1 | National Science Foundation | — | Detail |
Dec 18, 2015 | Grant | $241.25K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
SCG Holdings | — | Series B |